WO2021207698A1 - Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation - Google Patents
Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation Download PDFInfo
- Publication number
- WO2021207698A1 WO2021207698A1 PCT/US2021/026714 US2021026714W WO2021207698A1 WO 2021207698 A1 WO2021207698 A1 WO 2021207698A1 US 2021026714 W US2021026714 W US 2021026714W WO 2021207698 A1 WO2021207698 A1 WO 2021207698A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ampule
- medication
- wound
- reservoir
- topical applicator
- Prior art date
Links
- 230000000740 bleeding effect Effects 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims description 108
- 230000009467 reduction Effects 0.000 title description 4
- 239000003708 ampul Substances 0.000 claims abstract description 230
- 230000000699 topical effect Effects 0.000 claims abstract description 154
- 229940079593 drug Drugs 0.000 claims abstract description 145
- 239000003814 drug Substances 0.000 claims abstract description 145
- 230000007246 mechanism Effects 0.000 claims abstract description 134
- 230000004913 activation Effects 0.000 claims abstract description 16
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 8
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 8
- 230000003213 activating effect Effects 0.000 claims description 39
- 230000001567 anti-fibrinolytic effect Effects 0.000 claims description 22
- 239000008280 blood Substances 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 239000006260 foam Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 239000003146 anticoagulant agent Substances 0.000 claims description 6
- 229940127219 anticoagulant drug Drugs 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 238000013176 antiplatelet therapy Methods 0.000 claims description 4
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims description 3
- 102000007327 Protamines Human genes 0.000 claims description 3
- 108010007568 Protamines Proteins 0.000 claims description 3
- 229950008679 protamine sulfate Drugs 0.000 claims description 3
- 238000003466 welding Methods 0.000 claims description 3
- 229960002684 aminocaproic acid Drugs 0.000 claims description 2
- 239000006261 foam material Substances 0.000 claims 4
- 238000009434 installation Methods 0.000 claims 1
- 230000000717 retained effect Effects 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 75
- 208000027418 Wounds and injury Diseases 0.000 description 75
- 208000032843 Hemorrhage Diseases 0.000 description 31
- 241001465754 Metazoa Species 0.000 description 5
- 238000005299 abrasion Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010003226 Arteriovenous fistula Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000009344 Penetrating Wounds Diseases 0.000 description 2
- 206010051373 Wound haemorrhage Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
- 239000005465 B01AC22 - Prasugrel Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 108010056764 Eptifibatide Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 229940123583 Factor Xa inhibitor Drugs 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 229940127524 Protease-activated Receptor-1 Antagonists Drugs 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229940122388 Thrombin inhibitor Drugs 0.000 description 1
- 241000112708 Vates Species 0.000 description 1
- 229960000446 abciximab Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000000504 antifibrinolytic agent Substances 0.000 description 1
- 229940082620 antifibrinolytics Drugs 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960001080 cangrelor Drugs 0.000 description 1
- PAEBIVWUMLRPSK-IDTAVKCVSA-N cangrelor Chemical compound C1=NC=2C(NCCSC)=NC(SCCC(F)(F)F)=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O PAEBIVWUMLRPSK-IDTAVKCVSA-N 0.000 description 1
- 229960004588 cilostazol Drugs 0.000 description 1
- RRGUKTPIGVIEKM-UHFFFAOYSA-N cilostazol Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCC1=NN=NN1C1CCCCC1 RRGUKTPIGVIEKM-UHFFFAOYSA-N 0.000 description 1
- 229960003009 clopidogrel Drugs 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960004468 eptifibatide Drugs 0.000 description 1
- GLGOPUHVAZCPRB-LROMGURASA-N eptifibatide Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]1CC1=CN=C2[C]1C=CC=C2 GLGOPUHVAZCPRB-LROMGURASA-N 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960004197 prasugrel Drugs 0.000 description 1
- DTGLZDAWLRGWQN-UHFFFAOYSA-N prasugrel Chemical compound C1CC=2SC(OC(=O)C)=CC=2CN1C(C=1C(=CC=CC=1)F)C(=O)C1CC1 DTGLZDAWLRGWQN-UHFFFAOYSA-N 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003868 thrombin inhibitor Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 229960003425 tirofiban Drugs 0.000 description 1
- COKMIXFXJJXBQG-NRFANRHFSA-N tirofiban Chemical compound C1=CC(C[C@H](NS(=O)(=O)CCCC)C(O)=O)=CC=C1OCCCCC1CCNCC1 COKMIXFXJJXBQG-NRFANRHFSA-N 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960005044 vorapaxar Drugs 0.000 description 1
- ZBGXUVOIWDMMJE-QHNZEKIYSA-N vorapaxar Chemical compound C(/[C@@H]1[C@H]2[C@H](C(O[C@@H]2C)=O)C[C@H]2[C@H]1CC[C@H](C2)NC(=O)OCC)=C\C(N=C1)=CC=C1C1=CC=CC(F)=C1 ZBGXUVOIWDMMJE-QHNZEKIYSA-N 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
- A61M35/006—Portable hand-held applicators having means for dispensing or spreading integral media using sponges, foams, absorbent pads or swabs as spreading means
Definitions
- the present invention relates generally to devices having topical applicators, and more specifically to devices having topical applicators for reducing bleeding of a wound and/or achieving hemostasis at a wound.
- FIG. 5 is a cut-away view of a device according to embodiments of the present invention, in which the device comprises a reservoir, ampule, release mechanism, and topical applicator; and in which the release mechanism is at the wall of the reservoir.
- the ampule comprises a glass ampule.
- the ampule 130 may comprise a metered dose of the medication 132 ranging from about 1 mL to about 20 mL, or about 1 ml, to about 1.5 mL, or about 2,5 ml, to about 5 mL, or about 5 mL to about 10 ml,, or about 10 mL to about 15 mL, or about 15 mL to about 20 mL.
- the topical applicator ISO is attached to the reservoir via a fixation plate 160, as shown in FIGS. 1, 4, and 6.
- the fixation plate 160 is attached to the closed end of the reservoir via an adhesive or welding, and creates a seal to ensure that the medication 132 is directed to the topical applicator ISO.
- the fixation plate 160 comprises an opening (not shown) through which the medication 132 can contact the topical applicator 150.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Road Signs Or Road Markings (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Abstract
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022561623A JP2023521142A (ja) | 2020-04-09 | 2021-04-09 | 出血低減のためのデバイス並びにそれを作製及び使用する方法 |
CA3179861A CA3179861A1 (fr) | 2020-04-09 | 2021-04-09 | Dispositifs de reduction de saignement et leurs procedes de fabrication et d'utilisation |
EP21785331.6A EP4132630A4 (fr) | 2020-04-09 | 2021-04-09 | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation |
CN202180037288.8A CN115988997A (zh) | 2020-04-09 | 2021-04-09 | 用于减少出血的设备及其制造方法和使用方法 |
AU2021254290A AU2021254290A1 (en) | 2020-04-09 | 2021-04-09 | Devices for bleeding reduction and methods of making and using the same |
JP2023518768A JP2023545645A (ja) | 2020-10-05 | 2021-10-05 | 出血を減らすためのデバイス及びそのデバイスを製造及び使用する方法 |
EP21878399.1A EP4225421A1 (fr) | 2020-10-05 | 2021-10-05 | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation |
PCT/US2021/053641 WO2022076467A1 (fr) | 2020-10-05 | 2021-10-05 | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation |
KR1020237014925A KR20230098185A (ko) | 2020-10-05 | 2021-10-05 | 출혈 감소를 위한 장치 및 그 제조 및 사용 방법 |
CN202180074080.3A CN116490134A (zh) | 2020-10-05 | 2021-10-05 | 用于减少出血的装置及其制作和使用方法 |
AU2021358758A AU2021358758A1 (en) | 2020-10-05 | 2021-10-05 | Devices for bleeding reduction and methods of making and using the same |
CA3193893A CA3193893A1 (fr) | 2020-10-05 | 2021-10-05 | Dispositifs de reduction de saignement et leurs procedes de fabrication et d'utilisation |
US17/522,736 US11654057B2 (en) | 2020-04-09 | 2021-11-09 | Devices for bleeding reduction and methods of making and using the same |
US17/728,894 US11622893B2 (en) | 2020-04-09 | 2022-04-25 | Devices for bleeding reduction and methods of making and using the same |
US18/186,716 US20230329915A1 (en) | 2020-04-09 | 2023-03-20 | Devices for bleeding reduction and methods of making and using the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063007543P | 2020-04-09 | 2020-04-09 | |
US63/007,543 | 2020-04-09 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/053641 Continuation-In-Part WO2022076467A1 (fr) | 2020-04-09 | 2021-10-05 | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021207698A1 true WO2021207698A1 (fr) | 2021-10-14 |
Family
ID=78024157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/026714 WO2021207698A1 (fr) | 2020-04-09 | 2021-04-09 | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP4132630A4 (fr) |
JP (1) | JP2023521142A (fr) |
CN (1) | CN115988997A (fr) |
AU (1) | AU2021254290A1 (fr) |
CA (1) | CA3179861A1 (fr) |
WO (1) | WO2021207698A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022076467A1 (fr) * | 2020-10-05 | 2022-04-14 | Bio 54, Llc | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation |
US11622893B2 (en) | 2020-04-09 | 2023-04-11 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288159A (en) * | 1992-12-04 | 1994-02-22 | Minnesota Mining And Manufacturing Company | Liquid applicator with frangible ampoule and support |
US20050054967A1 (en) * | 2003-09-05 | 2005-03-10 | Gary Ashe | Fome swab applicator for fluid-containing ampule |
US6991394B2 (en) * | 2003-01-10 | 2006-01-31 | Medi-Flex, Inc. | Liquid applicator with a mechanism for fracturing multiple ampoules |
JP5128837B2 (ja) * | 2006-03-24 | 2013-01-23 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 環状接着構造体 |
US10478851B2 (en) * | 2015-05-29 | 2019-11-19 | Sulzer Mixpac Ag | Applicator for a fluid ingredient and method of activating an applicator |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020076255A1 (en) * | 2000-12-20 | 2002-06-20 | Hoang Minh Q. | Skin disinfectant applicator |
US11160962B2 (en) * | 2017-05-16 | 2021-11-02 | Professional Disposables International, Inc. | Antiseptic delivery device and method of use |
US20210322742A1 (en) * | 2018-08-21 | 2021-10-21 | 3M Innovative Properties Company | Flexible applicator handle region |
-
2021
- 2021-04-09 CN CN202180037288.8A patent/CN115988997A/zh active Pending
- 2021-04-09 WO PCT/US2021/026714 patent/WO2021207698A1/fr unknown
- 2021-04-09 EP EP21785331.6A patent/EP4132630A4/fr active Pending
- 2021-04-09 AU AU2021254290A patent/AU2021254290A1/en active Pending
- 2021-04-09 JP JP2022561623A patent/JP2023521142A/ja active Pending
- 2021-04-09 CA CA3179861A patent/CA3179861A1/fr active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288159A (en) * | 1992-12-04 | 1994-02-22 | Minnesota Mining And Manufacturing Company | Liquid applicator with frangible ampoule and support |
US6991394B2 (en) * | 2003-01-10 | 2006-01-31 | Medi-Flex, Inc. | Liquid applicator with a mechanism for fracturing multiple ampoules |
US20050054967A1 (en) * | 2003-09-05 | 2005-03-10 | Gary Ashe | Fome swab applicator for fluid-containing ampule |
JP5128837B2 (ja) * | 2006-03-24 | 2013-01-23 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 環状接着構造体 |
US10478851B2 (en) * | 2015-05-29 | 2019-11-19 | Sulzer Mixpac Ag | Applicator for a fluid ingredient and method of activating an applicator |
Non-Patent Citations (1)
Title |
---|
See also references of EP4132630A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11622893B2 (en) | 2020-04-09 | 2023-04-11 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
WO2022076467A1 (fr) * | 2020-10-05 | 2022-04-14 | Bio 54, Llc | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2021254290A1 (en) | 2022-11-03 |
CA3179861A1 (fr) | 2021-10-14 |
EP4132630A4 (fr) | 2024-06-05 |
JP2023521142A (ja) | 2023-05-23 |
CN115988997A (zh) | 2023-04-18 |
EP4132630A1 (fr) | 2023-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021207698A1 (fr) | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation | |
Bruns et al. | A new tissue adhesive for laceration repair in children | |
US20230329915A1 (en) | Devices for bleeding reduction and methods of making and using the same | |
US5466465A (en) | Transdermal drug delivery system | |
US8956065B2 (en) | Applicator for dispensing a surgical prep solution | |
US20160030368A1 (en) | Sinus anesthesia kit | |
Howell et al. | Outpatient wound preparation and care: a national survey | |
WO2018185555A2 (fr) | Systèmes, appareils, kits et méthodes pour des actes médicaux améliorés | |
US20110257610A1 (en) | Therapeutic Diffusion Wound Dressing and Filling Method | |
US20080139988A1 (en) | Bandage, topical agent-bearing package and topical agent-bearing element | |
US20160287814A1 (en) | Medical illumination device | |
KR20220031641A (ko) | 방출가능 항미생물제로 충전된 절개 드레이프를 포함하는 수술 부위 감염을 감소시키기 위한 상처 봉합 시스템 | |
Gupta et al. | Application of autologous platelet-rich plasma to graft donor sites to reduce pain and promote healing | |
CA3193893A1 (fr) | Dispositifs de reduction de saignement et leurs procedes de fabrication et d'utilisation | |
WO2022076467A1 (fr) | Dispositifs de réduction de saignement et leurs procédés de fabrication et d'utilisation | |
AU2021358758A9 (en) | Devices for bleeding reduction and methods of making and using the same | |
CN116490134A (zh) | 用于减少出血的装置及其制作和使用方法 | |
US20220280443A1 (en) | Transdermal Delivery System | |
Broman et al. | Emergency equipment on the field | |
Yan et al. | Equipment and supplies for sports and event medicine | |
US8690841B2 (en) | Wound care system | |
Fantl | Wound Care and Dressing Changes | |
Jackimczyk et al. | Management of pediatric wounds | |
Cowan | Wound Series Part 2: Introduction to Chronic Wound Treatments | |
Hill et al. | Marine Corps Operational Medicine: Determining Medical Supply Needs of the Surgical Company Ward, Lab, and Pharmacy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21785331 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022561623 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 3179861 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2021254290 Country of ref document: AU Date of ref document: 20210409 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021785331 Country of ref document: EP Effective date: 20221109 |